There is a document that looks more scientific than anything else in a supplement drawer, and it is the one most likely to be over-read. A purity report, a certificate of analysis, a lab sheet: three names for the same genre of paper, all of them answering a much narrower question than the marketing around them implies. Two reviews from the sports-nutrition literature are unusually good at drawing the line.
What the review of multi-ingredient products says
The first is a review of multi-ingredient pre-workout supplements: blends of caffeine, creatine, beta-alanine, amino acids and nitric oxide agents, sold on the theory that the combination does more than the parts. The performance findings are mixed and the review says so: acute use may help muscular endurance and subjective mood, with mixed results on force and power; chronic use alongside a periodized programme appears to augment lean mass, while the long-term effect on force, endurance and aerobic performance is less clear.
The sentence that matters for this article is about the labels, not the performance. The authors note that direct comparisons between formulations, or between a blend and a single ingredient, are often impossible because of the widespread use of proprietary blends that do not disclose the specific amounts of each ingredient. A list of ingredients is not a list of quantities. If a label says a proprietary blend, you cannot compute what a percentage of anything is, and a testing document that reports a compound does not tell you how much was in the capsule unless it reports a quantity too.
The same review ends with the point that matters most: many formulations may intentionally contain banned substances as ingredients, or unintentionally as contaminants. Contamination is not a metaphor. It means a compound nobody put on the label and nobody would have declared, present in a manufacturing stream or a raw material.
The regulatory gap, stated plainly
The second review puts the same problem in its institutional form. Between 40% and 100% of athletes use supplements, depending on sport, level and definition. Unless there is a nutrient deficiency, supplementation may not improve performance and may affect performance and health negatively. And here is the sentence: dietary supplements are classified as a subcategory of food, so manufacturers are not required to provide evidence of product safety and efficacy, or to obtain approval from any regulatory body, before marketing.
That is not a scandal; it is the design. But it has a direct consequence for anyone holding a lab sheet. A testing programme, whatever its quality, is a private commercial arrangement between a seller and a laboratory. It is not a regulatory approval, because no such approval exists to be granted in that category. And the authors add the anti-doping corollary: supplement use exposes athletes to the risk of ingesting banned substances or their precursors, and government regulatory systems do not include specific laboratory testing for the WADA list, so a separate framework is needed to assess that risk at all.
What a testing document can and cannot do
A purity report can tell you, for one sample submitted by someone, what a named method found. If it names the method, the compound and the number, that is a real and useful piece of information about that sample. Whether the sample came from the batch you received, whether the number is an assay of the whole contents or of a portion, and whether the panel looked for anything beyond the compounds printed on the sheet, are separate questions that only the report’s own details answer.
It cannot tell you about the next batch, and it cannot tell you about anything the panel did not look for. A report listing one compound is a statement about that compound. For the rest of the molecule’s chemistry, the honest answer is that nobody looked, and the page on how a purity report is actually produced explains which questions are worth asking of one: what a peptide purity report proves.
Neither review measured how often contamination actually happens, and neither can be used to say that any particular product on any particular shelf contains anything. The implication runs the other way: the documents are worth reading precisely because contamination is a real category of risk, and a sheet that answers one question about one sample is not a guarantee about the rest.
